UBS Group »

Nls Pharmaceutics shares owned by UBS Group

Quarter-by-quarter ownership of Nls Pharmaceutics (NLSPW) shares owned by UBS Group from 13F filings

Historical chart of UBS Group investment in Nls Pharmaceutics

Tip: Access up to 7 years of quarterly data

All positions including Nls Pharmaceutics held by UBS Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nls Pharmaceutics by UBS Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $55 1.0k 0.06
2022-12-31 $1.1k 3.7k 0.29
2022-09-30 $4.0k 16k 0.26
2022-06-30 $0 2.1k 0.00
2022-03-31 $999 2.0k 0.50
2021-12-31 $999 2.6k 0.38
2021-09-30 $2.0k 2.6k 0.76
2021-06-30 $3.0k 3.3k 0.90
2021-03-31 $3.0k 3.1k 0.96

More positions owned by UBS Group

Microsoft Corporation (MSFT)
Apple Call Option (AAPL)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr Russell 2000 Etf (IWM)
Amazon Call Option (AMZN)
NVIDIA Corporation (NVDA)
Ubs Group SHS (UBS)
Broadcom (AVGO)
JPMorgan Chase & Co. (JPM)
Alphabet Cap Stk Cl A (GOOGL)
Ishares Tr 20 Yr Tr Bd Etf (TLT)
Union Pacific Corporation (UNP)
Alphabet Cap Stk Cl C Put Option (GOOG)
Meta Platforms Cl A (META)

View all positions for UBS Group

Top funds holding Nls Pharmaceutics

Hudson Bay Capital Management
UBS Group

View all funds holding Nls Pharmaceutics